Three winners of 2019 Sandoz Healthcare Access Challenge (HACk) are announced at SXSW - Seite 3
About Sandoz HACk
The Sandoz Healthcare Access Challenge invites entrepreneurs and innovators in the field of digital technology to submit ideas with the potential to complement - or even positively disrupt -
established approaches to driving access to healthcare. As a global leader in generic and biosimilar medicines and a pioneer in the field of digital therapeutics, Sandoz is determined to play
a leading role in driving access to global healthcare by focusing on areas of unmet medical need. Sandoz sees the future of medicine as driven by increasingly strong collaboration between
healthcare companies and external partners, and the goal of Sandoz HACk is to help make this vision a reality - by identifying and supporting small, practical ideas with the potential to spark big
change.
For more information on Sandoz HACk, see here: https://www.sandoz.com/sandoz-hack
Join the conversation on Twitter and Facebook using #SandozHACk.
Lesen Sie auch
About Sandoz
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars and a pioneer in the emerging field of prescription
digital therapeutics. Our purpose is to pioneer access to healthcare by developing and commercializing novel, affordable approaches that address unmet medical need. Our broad portfolio of
high-quality medicines, covering all major therapeutic areas and increasingly focused on value-adding differentiated medicines, accounted for 2018 sales of USD 9.9 billion. Sandoz is headquartered
in Holzkirchen, in Germany's Greater Munich area.